Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
- PMID: 3210014
- DOI: 10.1007/BF01244786
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Abstract
Significant differences in the content of iron (III) and total iron were found in post mortem substantia nigra of Parkinson's disease. There was an increase of 176% in the levels of total iron and 225% of iron (III) in the substantia nigra of the parkinsonian patients compared to age matched controls. In the cortex (Brodmann area 21), hippocampus, putamen, and globus pallidus there was no significant difference in the levels of iron (III) and total iron. Thus the changes in total iron, iron (III) and the iron (II)/iron (III) ratio in the parkinsonian substantia nigra are likely to be involved in the pathophysiology and treatment of this disorder.
Similar articles
-
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.J Neurochem. 1989 Jun;52(6):1830-6. doi: 10.1111/j.1471-4159.1989.tb07264.x. J Neurochem. 1989. PMID: 2723638
-
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.J Neurochem. 1989 Feb;52(2):515-20. doi: 10.1111/j.1471-4159.1989.tb09150.x. J Neurochem. 1989. PMID: 2911028
-
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.J Neurochem. 1991 Mar;56(3):978-82. doi: 10.1111/j.1471-4159.1991.tb02017.x. J Neurochem. 1991. PMID: 1704426
-
Controversies about iron in parkinsonian and control substantia nigra.Acta Neurobiol Exp (Wars). 1997;57(3):217-25. doi: 10.55782/ane-1997-1229. Acta Neurobiol Exp (Wars). 1997. PMID: 9407708 Review.
-
The history of the research of iron in parkinsonian substantia nigra.J Neural Transm (Vienna). 2012 Dec;119(12):1507-10. doi: 10.1007/s00702-012-0894-8. Epub 2012 Sep 2. J Neural Transm (Vienna). 2012. PMID: 22941506 Free PMC article. Review.
Cited by
-
The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated Rebels.Cells. 2021 Mar 9;10(3):598. doi: 10.3390/cells10030598. Cells. 2021. PMID: 33803185 Free PMC article. Review.
-
Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson's disease.Acta Neuropathol Commun. 2021 Mar 22;9(1):47. doi: 10.1186/s40478-021-01145-2. Acta Neuropathol Commun. 2021. PMID: 33752749 Free PMC article.
-
Parkinson's disease: oxidative stress and therapeutic approaches.Neurol Sci. 2010 Oct;31(5):531-40. doi: 10.1007/s10072-010-0245-1. Epub 2010 Mar 10. Neurol Sci. 2010. PMID: 20221655 Review.
-
MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.J Neurol. 2006 Jan;253(1):26-32. doi: 10.1007/s00415-005-0914-9. Epub 2005 Jun 29. J Neurol. 2006. PMID: 15981079
-
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9843-8. doi: 10.1073/pnas.0403495101. Epub 2004 Jun 21. Proc Natl Acad Sci U S A. 2004. PMID: 15210960 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical